TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Age at full oral feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptoms assessed by Rivermead Post Concussion Symptoms Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Post instrumentation pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unprotected intercourse
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Primary Lung Cancer
Endpoint domain: Mortality/survival
Primary endpoint: Changed pain score in hand osteoarthritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cases detected
Endpoint domain: Adverse events/effects
Primary endpoint: Symptom Check-List (SCL) score variation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Presence of Retinal Blood Flow Autoregulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in pain assessment (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative ERM Development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients experiencing any dose-limiting toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Onset of efficacy of infliximab
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Motivation to eat and appetite
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in PHQ-15 total score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of Locoregional Failure/Progression (LRF/LRP)
Endpoint domain: Mortality/survival
Primary endpoint: Rate of Severe Treatment-Induced Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Suture associated granuloma outer diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suture associated granuloma central cellular element diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suture associated granuloma fibrous coat area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suture associated granuloma giant cell number
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Larger Size of Oocyte Diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Detection rate of a second cancer or precancerous lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in [18F]DASA-23 PET scan signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Scores of Prime-MD
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Anovaginal distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child's anxiety score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of men reporting justification for domestic violence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Effect of ISIS 681257 on renal function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Proportion of Patients Achieving IgG Levels ≥ 5 g/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: C-peptide Average Area Under the Curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Body awareness scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Amount of Change in Muscles Endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Detection of disability or dependence in daily activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of Participants Who Received a Cognitive Screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants Who Were Linked to Care Services
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Progression-free Survival Rate at 9 Months
Endpoint domain: Mortality/survival
Primary endpoint: Pulmonary thrombus burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in pain scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cumulative number of Gd-enhancing T1 lesions in brain MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pharmacokinetic parameters of bisoprolol and ramipril
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage decrease in blood homocysteine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Geometric Mean Ratio of Log Transformed Cmax of M12 Metabolite of GDC-0276
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric Mean Ratio of Log Transformed Maximum Plasma Concentration (Cmax) of GDC-0276
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric Mean Ratio of Log Transformed Cmax of M16 Metabolite of GDC-0276
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric Mean Ratio of Log Transformed Area Under the Curve From Time Zero to Last Quantifiable Concentration (AUClast) of GDC-0276
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Clinical Global Impression (CGI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Regional Availability of Metabotropic Glutamate Type-5 Receptors (mGluR5)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Functional Brain Network Engagement Associated With Response Inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Resting-state Functional Brain Network Activity, Fractional Amplitude of Low-frequency Fluctuations (fALFF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Therapeutic appropriateness of transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Outpatient Visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Severity of Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pathologic Response Rate (PaR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of subjects achieving long-term response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response to imatinib mesylate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Wound Re-epithelization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Stiffness of Thyroid Nodules
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Distribution of lymph node metastases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cardiovascular Risk Outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of glaucoma following cataract surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Receipt of preconception care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Degree of agreement between tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of hypnotic medication
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in rate of potentially inappropriate prescribing
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Deterioration by 6 Months - Older Cohort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Deterioration by 3 Years - Older Cohort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Deterioration by 6 Months - Younger Cohort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Deterioration by 3 Years - Younger Cohort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maximum percent decrease in FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Participants Surviving at Hospital Discharge
Endpoint domain: Mortality/survival
Primary endpoint: Fetal mitral valve growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Left ventricular growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Type 1 Hypersensitivity Reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Hamilton Depression Rating Scale (HDRS28)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean change in neutrophil priming in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Diagnostic sensitivity evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of Participants With a Dose Limiting Toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency and intensity of irritability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency and intensity of vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Frequency and intensity of distension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Healing rate of periapical lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attention and Visual Reasoning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: change of inflammatory tear cytokine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Participants Achieving Hemostatic Efficacy of Stopping an Ongoing Major Bleed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of Participants Who Had a Rapid Decrease of the International Normalized Ratio (INR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Identification of early oligometastatic disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Favorable preliminary measures of clinical performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and toxicity of immunizations
Endpoint domain: Adverse events/effects
Primary endpoint: Immunogenicity of tumor antigen-bearing dendritic cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Redox potential of urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of blood lymphocyte populations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: 17-item Hamilton Depression Rating Scale (HAM-D) total score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of subjects with 5% weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Variation of stroke volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Readmission by cardiac cause
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Accuracy of estimations matching ultrasound determined interspace
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: aerobic capacity (VO2 max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sexual interest and desire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Peri-procedural Myocardial Infarction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Radiostereometric analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Range of motion(ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful labour induction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Virological clearance rate at day 5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mortality rate at week 2
Endpoint domain: Mortality/survival
Primary endpoint: Acute Technical Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom From 30 Days Major Adverse Events (MAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Sniffing stick test change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Taste Strips
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of Ablation plus radiation
Endpoint domain: Adverse events/effects
Primary endpoint: Beck scale for anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of Days Abstinent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alcohol Consumption (Percentage of Negative Urines)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Subjects With Major Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Prevalence of ESBL-producing Enterobacteriaceae isolates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of participants completing study intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Daily active exercise minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Muscle Lipid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in Fat Inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Diagnostic accuracy for coronary artery stenosis detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Lead levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pesticide levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neck Disability Index (NDI) Score Improvement of at Least 15 Points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog Scale (VAS) Improvement of 2.0 cm for Neck Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serious Adverse Events Related to the Device
Endpoint domain: Adverse events/effects
Primary endpoint: Inter-recti distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Abdominal and lumbar muscles thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Mean Numerical Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Crohn's Disease Histologic Index of Severity (CDHIS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: analgesia request
Endpoint domain: Adverse events/effects
Primary endpoint: Change in frequency of fecal incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Diagnosis of Gallbladder malignancy
Endpoint domain: Mortality/survival
Primary endpoint: Graded Laboratory Abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: Need for mechanical ventilation after the procedure
Endpoint domain: Adverse events/effects
Primary endpoint: Positive rate of cell-free DNA vs cytological examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: AUC difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specific Phobia of Vomiting Inventory (SPOVI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Lower limb muscle power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peripheral PsA disease activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Intake of fruits and vegetables per day
Endpoint domain: Life impact
Endpoint subdomain: Dietary habits
Primary endpoint: Treatment drop-out
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Hamilton Depression Rating Scale (Ham-D-17)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Type of inflammatory cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Hormone assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Measurement of relapse
Endpoint domain: Adverse events/effects
Primary endpoint: Measurement of stone passage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Measurement of low frequency adverse events of interest
Endpoint domain: Adverse events/effects
Primary endpoint: Intragastric pH control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of eligible patients who enroll onto the study
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Risk of venous problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Symptoms assessed on PANSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Unstructured Imitation Assessment (UIA)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Early Intervention Parenting Self Efficacy Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Parent Fidelity
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Rate of grade 2 or greater adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum tolerated dose of PACE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: uncomplicated recovery after CABG surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: first attempt success rate of radial artery catheter insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of subjects achieving LDL-C goals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent of subjects achieving LDL-C goals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Middle Cerebral Artery Blood Flow Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Middle Cerebral Artery Blood Flow Reactivity to Hypercapnia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Comparability of pharmacokinetic parameter estimates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Patients Achieving ACR20 Response Criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of eligible nursing homes which agree to participate in study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Retention rate of nursing homes at 4 month follow-up
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Adherence rate of participants to the intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Desaturation during FOB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Prevention of death from aneurysm rupture or other aortic pathology
Endpoint domain: Mortality/survival
Primary endpoint: Prevention of rupture of aortic aneurysm or other aortic pathology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Number of Participants With All-Causality and Treatment Related Treatment-Emergent Adverse Events (AEs) or Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Dose Limiting or Intolerable Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Positive Anti-drug Antibody (ADA) Result
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of cough during swallowing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rate at end of treatment and end of follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Number of Health Risks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: volume of intraoperative bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in serum biomarkers of neurotoxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes